CAS 1265911-55-4

Ticagrelor-d7

CAS : 1265911-55-4

Formule : C₂₃H₂₁D₇F₂N₆O₄S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 529.61

Ref: 4Z-T-812

(1R,2R)-2-(2,5-difluorophenyl)cyclopropanamine

CAS : 1265911-55-4

Formule : C₉H₉F₂N

Couleur et forme : White To Off-White Solid

Masse moléculaire : 169.17

Ref: 4Z-T-81230

Ticagrelor-d7

Produit contrôlé

CAS : 1265911-55-4

Applications Labelled Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),

Formule : C₂₃₂H₇H₂₁F₂N₆O₄S

Couleur et forme : Yellow

Masse moléculaire : 529.61

Ref: TR-T437702

Ticagrelor-d7

Produit contrôlé

CAS : 1265911-55-4

Ticagrelor-d7 is a chromatographic, spectrometric, and bioequivalence analyte that is used for the treatment of acute coronary syndrome. It inhibits platelet aggregation by blocking the P2Y12 receptor on the platelet membrane. The drug is administered orally, and its pharmacokinetics are linear with a low propensity for accumulation. Ticagrelor-d7 has been shown to be equivalent to ticagrelor in terms of pharmacokinetics and antiplatelet activity in humans.

Formule : C₂₃H₂₁D₇F₂N₆O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 529.61 g/mol

Ref: 3D-QAC91155